Literature DB >> 11601835

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

V Fuster, L E Rydén, R W Asinger, D S Cannom, H J Crijns, R L Frye, J L Halperin, G N Kay, W W Klein, S Lévy, R L McNamara, E N Prystowsky, L S Wann, D G Wyse.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11601835     DOI： 10.1053/euhj.2001.2983

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  77 in total

Review 1.  Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.

Authors:  Vincent E Hagens; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C van Gelder
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

2.  A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.

Authors:  Paul Dorian; Suzan S Cvitkovic; Charles R Kerr; Eugene Crystal; Anne M Gillis; Peter G Guerra; L Brent Mitchell; Denis Roy; Allan C Skanes; D George Wyse
Journal:  Can J Cardiol       Date:  2006-04       Impact factor: 5.223

3.  Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?

Authors:  Emmanuel M Kanoupakis; George E Kochiadakis; Emmanuel G Manios; Nikolaos E Igoumenidis; Hercules E Mavrakis; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

4.  [Adequate anticoagulation in atrial fibrillation].

Authors:  T Heimig; A Altiner; J Tebbenjohanns
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

Review 5.  Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion.

Authors:  A A J Adgey; S J Walsh
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

6.  Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.

Authors:  P Korantzopoulos; T M Kolettis; A Papathanasiou; K K Naka; P Kolios; I Leontaridis; A Draganigos; C S Katsouras; J A Goudevenos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

7.  Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.

Authors:  Pablo Alonso-Coello; Victor M Montori; M Gloria Díaz; Philip J Devereaux; Gemma Mas; Ana I Diez; Ivan Solà; Mercè Roura; Juan C Souto; Sven Oliver; Rafael Ruiz; Blanca Coll-Vinent; Ignasi Gich; Holger J Schünemann; Gordon Guyatt
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

8.  Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.

Authors:  C-J A Lindholm; O Fredholm; S-J Möller; N Edvardsson; T Kronvall; T Pettersson; V Firsovaite; A Roijer; C J Meurling; P G Platonov; S B Olsson
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 9.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation.

Authors:  David D McManus; Jinseok Lee; Oscar Maitas; Nada Esa; Rahul Pidikiti; Alex Carlucci; Josephine Harrington; Eric Mick; Ki H Chon
Journal:  Heart Rhythm       Date:  2012-12-06       Impact factor: 6.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.